Through the foundation, Action to Cure Kidney Cancer (ACKC) sponsored a postdoctoral candidate’s kidney cancer research in the laboratory of Dr. Richard Childs at The National Heart Lung and Blood Institute (NHLBI). The goal of the program was to accelerate the search for new breakthroughs in the treatment of kidney cancer. With significant contributions from ACKC, the fellowship program supported the exploration of new and existing treatments, such as allogeneic stem cell transplantation, chemotherapy, radiation therapy, immunotherapy, vaccine therapy and drug treatments.